1. Follistatin and Endoglin: Potential Biomarkers of Endothelial Damage and Non-Relapse Mortality after Myeloablative Allogeneic Hematopoietic Cell Transplantation in Blood and Marrow Transplant Clinical Trials Network (BMT CTN) 0402 
Laura F. Newell, Todd E. Defor, Corey S. Cutler, Michael R. Verneris, Bruce R. Blazar, Joseph H. Antin, Alan Howard, Juan (Maggie) Wu, Margaret L. MacMillan, Angela Panoskaltsis-Mortari, Daniel J. Weisdorf, Shernan Holtan 
Biology of Blood and Marrow Transplantation 
Volume 23, Issue 3, Pages S73-S74 (March 2017)
DOI: /j.bbmt
Copyright © Terms and Conditions

2. Figure 1
Adjusted Non-Relapse Mortality by Composite Score of log(sEng) + log(FS).
Biology of Blood and Marrow Transplantation  , S73-S74DOI: ( /j.bbmt )
Copyright © Terms and Conditions